Translation of "inhibitor" to Chinese language:
Examples (External sources, not reviewed)
| If you take the obese mouse and give it an angiogenesis inhibitor, it loses weight. | 如果你给胖老鼠 一种血管增生的抑制剂 它减重 |
| Additionally, when some hypoglycemic drugs such as melbine (DMBG) or α glucosidase inhibitor are taken at very onset, patients might happen to side effects like abdominal distension, abdominal pain and diarrhea. | 此外 某些降糖药譬如刚开始服二甲双胍或α葡萄糖苷酶抑制剂等降糖药时 也可能出现腹胀 腹痛 腹泻等副作用 |
| Tasuku Honjo discover the T cell inhibitor receptor PD 1 in 1992, and he initiated the cancer immunotherapy based on it in 2013. His merits and achievements ranked the first of the Annual Top 10 Scientific Breakthroughs of Science . | 本庶佑于1992年发现T细胞抑制受体PD 1 2013年依此开创了癌症免疫疗法 功绩名列 Science 年度十大科学突破之首 |
| We have shown that PARP inhibitors are effective at killing BRCA2 defective breast cancer cells, and that the tumors they cause can fully regress and disappear following treatment with a PARP inhibitor. The next step is to investigate how efficient this treatment is in human patients. | 我们已经展示了PARP抑制剂如何能够有效杀死有BRCA2缺陷的乳腺癌细胞 并且由它们所引发的肿瘤能在使用PARP抑制剂后缩小并彻底消失 下一步要做的就是研究这种治疗法对人类患者究竟有多有效 我们正准备启动临床实验以测定这些PARP抑制剂在治疗转移性胸壁肿瘤中如何有效 |
| Recently, my research group, along with researchers in London, provided some real hope for carriers of mutated BRCA1 or BRCA2 genes. Both research teams describe how the use of a chemical inhibitor can kill tumor cells that have either a BRCA1 or BRCA2 gene defect causing hereditary breast cancer. | 最近 我的研究小组和伦敦的研究者们一起 为那些变异BRCA1 或 BRCA2基因携带者提供了真正的希望 两个研究团队描述了如何使用一种化学抑制剂消灭那些携带会引起遗传性乳腺癌的BRCA1或者BRCA2基因缺陷的肿瘤细胞 这种新治疗手段只以肿瘤细胞为目标 不会影响体内的其他健康细胞 该发现也能够防止遗传性乳腺癌转化为肿瘤 |
| The addition of this inhibitor to intensive chemotherapy has dramatically improved the outlook for these children, increasing the rate of three year event free survival from 35 to 80 . The development of targeted new agents is likely to affect outcomes for other subtypes of childhood cancer, including anaplastic large cell lymphoma and other types of leukemias. | 在高剂量化疗中添加这种抑制剂已经让患儿的治疗前景显著改善 并将三年无并发症存活率从35 提高到80 针对性的新药研发可能影响其他儿童癌症亚型的治疗效果 包括间变性大细胞淋巴瘤和其他类型的白血病 |